Takeda

1424 articles with Takeda

• Takeda Pharmaceuticals North America, Inc. Responds to the FDA Advisory Committee Recommendation

  7/31/2007

• Takeda's Investigational DPP-4 Inhibitor Demonstrated Efficacy in Reducing Glucose Levels in Early Phase Study

  6/25/2007

• Takeda Pharmaceuticals North America, Inc. Release: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions

  6/22/2007

• iBIO: Leading Companies Takeda Pharmaceuticals North America, Inc., Baxter Healthcare Corporation. and Astellas Pharma US, Inc. Invest $1 million in Illinois' Biotechnology Future

  6/21/2007

• iBIO Institute Release: Leading Companies Invest $1 Million in Illinois' Biotechnology Future

  6/20/2007

• Takeda Pharmaceuticals North America, Inc. Study Demonstrated ROZEREM(TM) (ramelteon) Does Not Affect Middle-of-the-Night Balance in Older Adults with Insomnia

  6/14/2007

• Archemix Corporation and Takeda Pharmaceutical Co. Ltd. (Jobs) to Enter into Collaboration for Discovery and Development of Aptamer Therapeutics

  6/11/2007

• BioWa and Takeda Pharmaceutical Co. Ltd. Announce Licensing of BioWa's POTELLIGENT(R) Technology for Use in Antibody Research and Development

  5/30/2007

• Takeda Pharmaceuticals North America, Inc. Release: New Study Suggests No Significant Impairment in Middle-of-the-Night Balance, Mobility or Memory in Older Adults Using Ramelteon

  5/23/2007

• Takeda Pharmaceuticals North America, Inc. New Study Suggests no Significant Impairment in Middle-of-the-Night Balance, Mobility or Memory in Older Adults Using Ramelteon

  5/23/2007

• Takeda Pharmaceuticals North America, Inc. Release: New Study Demonstrates That Lubiprostone May Improve Symptom Relief Rates in Adults With Irritable Bowel Syndrome With Constipation (IBS-C)

  5/21/2007

• Takeda Pharmaceutical Co. Ltd.(Jobs), Eisai Company, Ltd. Takeovers Raise Biotech Costs for Merck & Co., Inc.(Jobs), Novartis International AG(Jobs)

  4/19/2007

• Ajinomoto and Takeda Pharmaceutical Co. Ltd. Release: A Once-weekly Formulation of Risedronate Sodium Hydrate, an Antiosteoporotic Agent, Was Approved in Japan

  4/18/2007

• Affymax, Inc. and Takeda Pharmaceutical Co. Ltd. Honored with the Allicense 2007 Breatkthrough Alliance Award for Their Exclusive Global Agreement for Hematide(TM)

  4/18/2007

• Takeda Pharmaceuticals North America, Inc. Commits $1.44 Million to American Diabetes Association Postdoctoral Fellowship Programs

  4/5/2007

• Takeda Pharmaceutical Co. Ltd. Obtains Rights for HPV Drug from 3M Company

  3/30/2007

• China Biopharma Inc. Forms Distribution Agreement with World-Renowned Japanese Pharmaceutical Company Takeda Pharmaceutical Co. Ltd.

  3/20/2007

• Takeda Pharmaceutical Co. Ltd. to Acquire Paradigm Medical

  3/12/2007

• More Fractures In Women on Takeda Pharmaceutical Co. Ltd. (Jobs) Diabetes Drug Says FDA

  3/9/2007

• Takeda Pharmaceuticals North America, Inc. and TAP Pharmaceutical Products Inc. to Promote Sucampo Pharmaceuticals, Inc.'s AMITIZA(R) in the United States

  2/26/2007